MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.resinv.2026.101450

Медицинская библиотека · Respiratory investigation · 2026

Pulmonary vascular resistance is associated with two-year clinical outcomes in non-hypoxemic COPD with mild pulmonary hemodynamic abnormalities.

Idei Shun, Tanaka Yosuke, Dong Fushi, Okamura Ken, Kaburaki Shota, Tanaka Toru, Shimizu Ayumi, Takeuchi Susumu, Taniuchi Namiko, Kamio Koichiro, Kasahara Kazuo, Wu Lina, Seike Masahiro, Hino Mitsunori

СтатьяНаблюдательное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Pulmonary hypertension (PH) complicates chronic obstructive pulmonary disease (COPD) and is associated with adverse outcomes. However, the clinical relevance of pulmonary vascular resistance (PVR) in non-hypoxemic COPD patients without severe PH remains unclear.

METHODS

This pre-specified secondary analysis of a prospectively registered cohort (UMIN000042159) included non-hypoxemic COPD patients who underwent right heart catheterization and were managed without PH-targeted therapy. Patients were classified as having preliminary pulmonary vascular abnormality (resting mean pulmonary artery pressure [mPAP] ≤ 20 mmHg with exercise-related elevation during a study-specific exercise protocol) or mild-to-moderate PH (20 < resting mPAP <35 mmHg). The primary outcome was two-year overall survival. Secondary outcomes included home-stay survival and functional capacity assessed by 6-min walk distance (6MWD), metabolic equivalents (MET), and modified Medical Research Council (mMRC) dyspnea score.

RESULTS

Thirty-seven patients were analyzed. During follow-up, 18 patients lost independent living and 11 died. Higher PVR and mPAP were associated with reduced home-stay survival and overall survival. PVR demonstrated the strongest association with mortality (hazard ratio 1.45, p = 0.0007). PVR was correlated with mMRC (ρ = 0.65), 6MWD (ρ = -0.62), and MET (ρ = -0.49). Spirometric indices were not predictive of survival.

CONCLUSIONS

In non-hypoxemic COPD patients without severe PH, pulmonary vascular resistance was associated with functional limitation and two-year prognosis. suggesting that pulmonary vascular burden is an important determinant of near-term outcomes.

CLINICAL TRIAL REGISTRATION: UMIN-CTR (UMIN000042159).

Для цитирования: Idei Shun, Tanaka Yosuke, Dong Fushi, Okamura Ken, Kaburaki Shota, Tanaka Toru, Shimizu Ayumi, Takeuchi Susumu, Taniuchi Namiko, Kamio Koichiro, Kasahara Kazuo, Wu Lina, Seike Masahiro, Hino Mitsunori. Pulmonary vascular resistance is associated with two-year clinical outcomes in non-hypoxemic COPD with mild pulmonary hemodynamic abnormalities.. Respiratory investigation. 2026. DOI: 10.1016/j.resinv.2026.101450.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.